AbCellera Biologics Inc.
Nasdaq ABCL · Vancouver, British Columbia, Canada
AbCellera Biologics Inc. is a clinical trial sponsor based in Vancouver, British Columbia, Canada, listed as Nasdaq ABCL. It has 2 active clinical trials with 176 planned participants.
Trial track record · since 2021
Financials · Nasdaq ABCL
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about AbCellera Biologics Inc
AbCellera Biologics Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 176 planned participants. Since 2021 it has completed 0 trials and stopped 0 early.
AbCellera Biologics Inc is based in Vancouver, British Columbia, Canada and is listed as Nasdaq ABCL. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with AbCellera Biologics Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-16.
Approve Suite is not affiliated with AbCellera Biologics Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.